In this video, health-care analysts David Williamson and Max Macaluso dive back in to the growing diabetes treatment market to focus on Novo Nordisk. They discuss the company's competitive position and management's assertion that new competition will boost sales thanks to increased attention.
Many investors are attracted to Novo Nordisk because of its gorwing position in a growing market. But there is more than one approach to building long-term wealth and retiring well. In our free report "3 Stocks That Will Help You Retire Rich," we reveal some stocks that could help you as well as some winning wealth-building strategies. Click here to keep reading.
